<?xml version="1.0" encoding="UTF-8" standalone="yes"?><oembed><version><![CDATA[1.0]]></version><provider_name><![CDATA[Ned Hamson&#039;s Second Line View of the News]]></provider_name><provider_url><![CDATA[http://nedhamsonsecondlineviewofthenews.com]]></provider_url><author_name><![CDATA[nedhamson]]></author_name><author_url><![CDATA[https://nedhamsonsecondlineviewofthenews.com/author/nedhamson/]]></author_url><title><![CDATA[FDA approves new medication for uncomplicated urinary tract infections in women &#8211;&nbsp;UPI.com]]></title><html><![CDATA[<blockquote class="wp-embedded-content" data-secret="zDi5wqkrON"><a href="https://nedhamsonsecondlineviewofthenews.com/2024/04/24/fda-approves-new-medication-for-uncomplicated-urinary-tract-infections-in-women-upi-com/">FDA approves new medication for uncomplicated urinary tract infections in women &#8211;&nbsp;UPI.com</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://nedhamsonsecondlineviewofthenews.com/2024/04/24/fda-approves-new-medication-for-uncomplicated-urinary-tract-infections-in-women-upi-com/embed/#?secret=zDi5wqkrON" width="440" height="248" title="&#8220;FDA approves new medication for uncomplicated urinary tract infections in women &#8211;&nbsp;UPI.com&#8221; &#8212; Ned Hamson&#039;s Second Line View of the News" data-secret="zDi5wqkrON" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script type="text/javascript">
/* <![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
/* ]]> */
</script>
]]></html><type><![CDATA[rich]]></type><thumbnail_url><![CDATA[https://www.inoreader.com/camo/s5BQ4YOREDY2Umm1DzVTLyhvo5ehS8US89lek2aj9ffI,b64/aHR0cHM6Ly9jZG5waC51cGkuY29tL3BoL3N0L3RoLzU4ODE3MTM5OTc5ODIvMjAyNC91cGlfY29tLzc5ODZkNGRiNTA3ZDhmZTY3YTI2OWU0MGZiZWQxNmVlL3YxLjUvRkRBLWFwcHJvdmVzLW5ldy1tZWRpY2F0aW9uLWZvci11bmNvbXBsaWNhdGVkLXVyaW5hcnktdHJhY3QtaW5mZWN0aW9ucy1pbi13b21lbi5qcGc]]></thumbnail_url><thumbnail_width><![CDATA[400]]></thumbnail_width><thumbnail_height><![CDATA[267]]></thumbnail_height></oembed>